Immune Checkpoint Inhibitors in Cancer

Book Immune Checkpoint Inhibitors in Cancer Cover

Read or download book entitled Immune Checkpoint Inhibitors in Cancer written by Fumito Ito and published by Elsevier Health Sciences in PDF, EPUB and Kindle Format. Click Get This Book button to download or read online books. Join over 650.000 happy Readers and READ as many books as you like. We cannot guarantee that Immune Checkpoint Inhibitors in Cancer book is available in the library.

  • Publisher : Elsevier Health Sciences
  • Release : 03 September 2018
  • ISBN : 9780323549509
  • Page : 400 pages
  • Rating : 4.5/5 from 103 voters

Download Immune Checkpoint Inhibitors in Cancer in PDF, Epub and Kindle

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today’s available information on this timely topic into one convenient resource.

GET THIS BOOK

Immune Checkpoint Inhibitors in Cancer

Immune Checkpoint Inhibitors in Cancer
  • Author : Fumito Ito,Marc Ernstoff
  • Publisher : Elsevier Health Sciences
  • Release Date : 2018-09-03
  • ISBN : 9780323549509
GET THIS BOOKImmune Checkpoint Inhibitors in Cancer

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how

Cutaneous Melanoma

Cutaneous Melanoma
  • Author : Anonim
  • Publisher : Unknown
  • Release Date : 2022-12-01
  • ISBN : OCLC:1125727614
GET THIS BOOKCutaneous Melanoma

Regulation of Cancer Immune Checkpoints

Regulation of Cancer Immune Checkpoints
  • Author : Jie Xu
  • Publisher : Springer Nature
  • Release Date : 2020-03-17
  • ISBN : 9789811532665
GET THIS BOOKRegulation of Cancer Immune Checkpoints

This book systematically reviews the most important findings on cancer immune checkpoints, sharing essential insights into this rapidly evolving yet largely unexplored research topic. The past decade has seen major advances in cancer immune checkpoint therapy, which has demonstrated impressive clinical benefits. The family of checkpoints for mediating cancer immune evasion now includes CTLA-4, PD-1/PD-L1, CD27/CD70, FGL-1/LAG-3, Siglec-15, VISTA (PD-1L)/VSIG3, CD47/SIRPA, APOE/LILRB4, TIGIT, and many others. Despite these strides, most patients do not

SITC’s Guide to Managing Immunotherapy Toxicity

SITC’s Guide to Managing Immunotherapy Toxicity
  • Author : Marc S. Ernstoff, MD,Igor Puzanov, MD, MSCI, FACP,Caroline Robert, MD, PhD,Adi M. Diab, MD,Peter M. Hersey, MD, PhD
  • Publisher : Springer Publishing Company
  • Release Date : 2019-03-15
  • ISBN : 9780826172150
GET THIS BOOKSITC’s Guide to Managing Immunotherapy Toxicity

The Society for Immunotherapy of Cancer's handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured

Advances in Precision Medicine Oncology

Advances in Precision Medicine Oncology
  • Author : Hilal Arnouk,Bassam Abdul Rasool Hassan
  • Publisher : Unknown
  • Release Date : 2021
  • ISBN : 1839688696
GET THIS BOOKAdvances in Precision Medicine Oncology

Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review

Immunotherapy of Hepatocellular Carcinoma

Immunotherapy of Hepatocellular Carcinoma
  • Author : Tim F. Greten
  • Publisher : Springer
  • Release Date : 2017-10-04
  • ISBN : 9783319649580
GET THIS BOOKImmunotherapy of Hepatocellular Carcinoma

In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of

Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors

Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,National Cancer Policy Forum
  • Publisher : National Academies Press
  • Release Date : 2019-09-05
  • ISBN : 9780309490894
GET THIS BOOKAdvancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors

In recent years, significant progress has been made in the clinical development and use of various types of cancer immunotherapy, all of which rely on the immune system to fight cancer. The majority of new cancer drug applications submitted to the Food and Drug Administration (FDA) are for immunotherapies or combinations involving immunotherapies. One type of immunotherapy is an immune checkpoint inhibitor. Cells in the human body have proteins that regulate the immune system response to foreign invaders (e.g.,

Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors

Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,National Cancer Policy Forum
  • Publisher : National Academies Press
  • Release Date : 2019-10-05
  • ISBN : 9780309490863
GET THIS BOOKAdvancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors

In recent years, significant progress has been made in the clinical development and use of various types of cancer immunotherapy, all of which rely on the immune system to fight cancer. The majority of new cancer drug applications submitted to the Food and Drug Administration (FDA) are for immunotherapies or combinations involving immunotherapies. One type of immunotherapy is an immune checkpoint inhibitor. Cells in the human body have proteins that regulate the immune system response to foreign invaders (e.g.,

Abeloff's Clinical Oncology E-Book

Abeloff's Clinical Oncology E-Book
  • Author : Martin D. Abeloff,James O. Armitage,John E. Niederhuber,Michael B. Kastan,W. Gillies McKenna
  • Publisher : Elsevier Health Sciences
  • Release Date : 2008-06-30
  • ISBN : 9781437720563
GET THIS BOOKAbeloff's Clinical Oncology E-Book

Carrying on the tradition established by its founding editor, the late Dr. Martin Abeloff, the 4th Edition of this respected reference synthesizes all of the latest oncology knowledge in one practical, clinically focused, easy-to-use volume. It incorporates basic science, pathology, diagnosis, management, outcomes, rehabilitation, and prevention – all in one convenient resource – equipping you to overcome your toughest clinical challenges. What's more, you can access the complete contents of this Expert Consult title online, and tap into its unparalleled guidance wherever

Immune Checkpoint Blockade

Immune Checkpoint Blockade
  • Author : Yago Pico de Coaña
  • Publisher : Humana Press
  • Release Date : 2019-01-22
  • ISBN : 1493989782
GET THIS BOOKImmune Checkpoint Blockade

This detailed volume describes a series of techniques that are essential for evaluating the efficacy of new checkpoint blockade therapies as well as understanding the mechanisms behind the therapies that have already been approved. Beginning with a section on describing the tumor microenvironment and evaluating the immune system at a systemic level, the book continues by covering functional assays that provide answers to questions that may be raised after studying the immune system and its responses to immunotherapies, as well

Thoracic Malignancies

Thoracic Malignancies
  • Author : Anonim
  • Publisher : Demos Medical Publishing
  • Release Date : 2010-03-08
  • ISBN : 1935281801
GET THIS BOOKThoracic Malignancies

Thoracic Malignancies: Thoracic Malignancies is the first title in Radiation Medicine Rounds. These tumors take more lives than any others and they are among the most preventable of tumors. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management. Thoracic Malignancies addresses the multi-disciplinary nature of the care of these tumors. There is representation from radiation oncology, medical oncology, and surgery ensuring a well-rounded summarization of current practice. Included are chapters on lung

Dying in America

Dying in America
  • Author : Institute of Medicine,Committee on Approaching Death: Addressing Key End-of-Life Issues
  • Publisher : National Academies Press
  • Release Date : 2015-03-19
  • ISBN : 9780309303132
GET THIS BOOKDying in America

For patients and their loved ones, no care decisions are more profound than those made near the end of life. Unfortunately, the experience of dying in the United States is often characterized by fragmented care, inadequate treatment of distressing symptoms, frequent transitions among care settings, and enormous care responsibilities for families. According to this report, the current health care system of rendering more intensive services than are necessary and desired by patients, and the lack of coordination among programs increases

Fast Facts: Immuno-Oncology

Fast Facts: Immuno-Oncology
  • Author : S. Clarke,B.T. Li
  • Publisher : Karger Medical and Scientific Publishers
  • Release Date : 2021-06-29
  • ISBN : 9783318068221
GET THIS BOOKFast Facts: Immuno-Oncology

The treatment of cancer has been revolutionized by therapies that modulate the immune system, with benefits for quality of life and survival. Standards of care have changed to reflect developments, but the area is moving fast. Keeping abreast of new therapies and trial data can be challenging. This second edition of 'Fast Facts: Immuno-Oncology' takes you from the fundamentals of immunology through to the new concepts of immunoediting and immunotherapy and likely future directions. Whether you have worked in oncology

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers
  • Author : Andrea Necchi,Philippe E. Spiess
  • Publisher : Springer Nature
  • Release Date : 2022-01-03
  • ISBN : 9783030805463
GET THIS BOOKNeoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers

This book aims to provide readers with a current overview of enrolling trials with immune-checkpoint inhibitors in the preoperative setting of localized bladder cancer, renal cell carcinoma, and prostate cancer. The advent of immunotherapy has revolutionized treatments of genitourinary malignancy and evolved strategies for multidisciplinary management. This book explains neoadjuvant checkpoint inhibitors in localized genitourinary cancers, providing insights into the mechanisms of response and development of resistance of cancer cells to immunotherapy. It debates optimal trial design of preoperative checkpoint

The Basics of Cancer Immunotherapy

The Basics of Cancer Immunotherapy
  • Author : Haidong Dong,Svetomir N. Markovic
  • Publisher : Springer
  • Release Date : 2018-01-05
  • ISBN : 9783319706221
GET THIS BOOKThe Basics of Cancer Immunotherapy

This book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize